Grafa News and Videos — Page 248

Gilead Sciences (NASDAQ:GILD) and Merck (NYSE:MRK) said their once-weekly HIV pill maintained suppression through Week 48 in two Phase 3 trials.

Charles Schwab (NYSE:SCHW) reported record Q2 net revenue of $7.07 billion, up 21%, while net income increased 32% to $2.8 billion.

Microsoft (NASDAQ:MSFT) agreed to spend billions on Mistral AI’s European infrastructure while expanding the French startup’s distribution through Azure.

Tempus AI (NASDAQ:TEM) agreed to acquire Personalis (NASDAQ:PSNL) for $1.5 billion, adding cancer-monitoring technology to its oncology platform.

Novo Nordisk (NYSE:NVO) sued Eli Lilly (NYSE:LLY) in New Jersey, challenging GLP-1 advertisements served more than 700 million times.

Bluejay Diagnostics (NASDAQ:BJDX) completed enrollment of 750 patients in its SYMON-II study evaluating 28-day sepsis mortality risk.

Forestar Group (NYSE:FOR) reported fiscal Q3 revenue of $407.0 million, up 4%, as residential lot sales increased 1% to 3,659.

Southern First Bancshares (NASDAQ:SFST) reported Q2 2026 net income of $11.2 million as total revenue increased 25% to $35.9 million.

Hasbro (NASDAQ:HAS) reported Q2 revenue of $1.14 billion, up 16%, and raised its 2026 revenue-growth outlook to 5%–7%.

Ally Financial (NYSE:ALLY) reported Q2 2026 GAAP net revenue of $2.286 billion, up 10%, while common shareholder net income reached $367 million.